Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT03859232
Other study ID # H-41712
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date March 29, 2018
Est. completion date December 28, 2022

Study information

Verified date May 2023
Source Baylor College of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to: 1) investigate the effectiveness of waterproof spica cast using Delta-Dry® Pantaloon and cast padding (BSN medical, USA) versus standard gortex pantaloon with cotton cast padding in maintaining the femur fracture and developmental dysplasia of the hip reduction after application of hip spica; 2) evaluate the overall quality ratings of both cast paddings from the perspectives of the patient and the clinicians; and 3) determine the cost difference between the both cast paddings.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date December 28, 2022
Est. primary completion date March 28, 2022
Accepts healthy volunteers No
Gender All
Age group 0 Years to 5 Years
Eligibility Inclusion Criteria: - Paediatric patients (<6 years old) diagnosed with developmental dysplasia of the hip or femur fracture who present to Texas Children's Hospital and plan to be treated with a spica cast. Exclusion Criteria: - Patients with thigh diameter more than 13.4 inches will be excluded because of the size limitation of the Delta-Dry Pantaloon - Patients with femur fracture who present for treatment more than 2 weeks from the date of injury, comminuted fracture, non-displaced fracture, or with other surgical comorbidity

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Delta Dry® Waterproof Pantaloon
Cast with newer waterproof material developed to reduce the skin complications associated with traditional cotton liners.
Cotton Padding
Cast with traditional cotton liner.

Locations

Country Name City State
United States Texas Children's Hospital Houston Texas

Sponsors (1)

Lead Sponsor Collaborator
Baylor College of Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effectiveness as a measure of change in ratings at different time points The primary outcome (effectiveness) will be measured based on the change in ratings to the following variables/factors using a 10 point likert scale (1 being very poor and 10 being excellent):
Comfort, Ability for the cast to dry if it became wet, Cast odor, Cast durability, Protection from skin irritation, Ease of care in the cast, Ease of Application, Padding Aesthetics, Application Time, Skin Condition, Lack of Maceration / Excoriation, Cast Odor, Padding Condition, and Ease of Removal.
These will be collected at baseline, 2, 6 and 12 weeks post-application.
Baseline, 2, 6 and 12 weeks post-application
Secondary Quality The secondary outcome (quality) will be measured based on rating to the following using a 10 point likert scale (1 being very poor and 10 being excellent):
Overall Quality
Baseline, 2, 6 and 12 weeks post-application
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06007833 - Physical Therapy Applications on the Hip and Defined Functional Parameters in Children With Developmental Hip Dysplasia N/A
Not yet recruiting NCT01437124 - Metal Ions in Ceramic on Metal Total Hip Arthroplasty N/A
Completed NCT05853510 - Mid-term Functional Comparisons of Unilateral and Bilateral Developmental Dysplasia of the Hip
Completed NCT05348421 - Postoperative Analgesic Effect of Two Peripheral Nerve Blocks for Hip Surgery in Pediatrics N/A
Recruiting NCT03107520 - Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDH Early Phase 1
Not yet recruiting NCT05822700 - Outcome Of Using Transfixing K Wire ln DDH With Hypoplastic Head And Severe Generalised Ligamentous Laxity N/A
Recruiting NCT04101903 - Evaluation of Aid to Diagnosis for Congenital Dysplasia of the Hip in General Practice N/A
Completed NCT04563819 - Genetic Mechanisms and Additional Risk Factors Underlying Hip Dysplasia
Active, not recruiting NCT05186168 - Corin MiniHip and Trinity Cup Clinical Surveillance Study
Recruiting NCT05188235 - Sound Conduction of Infant Hips N/A
Completed NCT04007016 - A New Pelvic Osteotomy Method for Open Reduction
Completed NCT03608475 - Assessing a Limited Ultrasound Protocol in DDH N/A
Recruiting NCT02185365 - Evaluation of T1rho Magnetic Resonance Imaging for Diagnosis of Cartilage Lesions in Hips With Developmental Dysplasia
Completed NCT05929105 - AI-assisted Preoperative Planning Technology for THA for DDH
Active, not recruiting NCT02431871 - Sequelae of Developmental Dysplasia of the Hip
Completed NCT02945995 - Outcome After Arthroscopic Surgery in Patients Treated With PAO N/A
Completed NCT01345838 - Acetabular Labral Tear in Dysplastic Hips
Completed NCT01866527 - Selective Ultrasound Screening for DDH 1991-2006 N/A
Recruiting NCT05238935 - Do All Patients With Congenital Hip Dysplasia Corrected Operatively Need Physiotherapy N/A
Not yet recruiting NCT06233487 - Reliability of Ultrasound Metrics Used in Hip Dysplasia Diagnostics - a Prospective Study N/A